2,417 results match your criteria Limb-Girdle Muscular Dystrophy


Identification of a novel SGCA missense mutation in a case of limb-girdle muscular dystrophy 2D with the absence of four sarcoglycan proteins.

Neuropathology 2019 Apr 15. Epub 2019 Apr 15.

Department of Neurology, The Second Hospital of Hebei Medical University, Hebei, China.

Limb-girdle muscular dystrophy 2D (LGMD2D) is caused by mutations in the α-sarcoglycan gene (SGCA). Due to lack of specificity, it is impossible to identify LGMD2D only by clinical symptoms and conventional immunohistochemical staining. The loss of any protein (α-, β-, γ-, δ-sarcoglycan) that represent sarcoglycanopathy may cause reduction or absence of the other three proteins. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/neup.12549DOI Listing
April 2019
1 Read

ERK1/2 signaling induces skeletal muscle slow fiber-type switching and reduces muscular dystrophy disease severity.

JCI Insight 2019 Apr 9;5. Epub 2019 Apr 9.

Mitogen-activated protein kinase (MAPK) signaling consists of an array of successively acting kinases. The extracellular signal-regulated kinases 1/2 (ERK1/2) are major components of the greater MAPK cascade that transduce growth factor signaling at the cell membrane. Here we investigated ERK1/2 signaling in skeletal muscle homeostasis and disease. Read More

View Article

Download full-text PDF

Source
http://insight.jci.org/articles/view/127356
Publisher Site
http://dx.doi.org/10.1172/jci.insight.127356DOI Listing
April 2019
22 Reads

A novel COL6A2 mutation causing late-onset limb-girdle muscular dystrophy.

J Neurol 2019 Apr 8. Epub 2019 Apr 8.

Neuromuscular Research Center, Department of Neurology, Tampere University and University Hospital, Tampere, Finland.

Limb-girdle muscular dystrophies (LGMD) are genetic disorders characterized by weakness of predominantly proximal limb and trunk muscles due to progressive loss of muscle tissue. Collagen VI-related muscular dystrophies usually display more generalized muscle involvement combined with contractures and/or hyperlaxity of distal finger joints. LGMD-like phenotype of collagenopathy has only rarely been described and as reported is usually of childhood onset. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00415-019-09307-yDOI Listing
April 2019
1 Read
3.377 Impact Factor

Titin in muscular dystrophy and cardiomyopathy: Urinary titin as a novel marker.

Clin Chim Acta 2019 Apr 5;495:123-128. Epub 2019 Apr 5.

Department of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.

Titin, encoded by the gene TTN, is the largest human protein, and plays central roles in sarcomeric structures and functions in skeletal and cardiac muscles. Mutations of TTN are causally related to specific types of muscular dystrophies and cardiomyopathies. A developed methodology of next generation sequencing has recently led to the identification of novel TTN mutations in such diseases. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cca.2019.04.005DOI Listing
April 2019
2 Reads

The Caveolin-3 P104L mutation in LGMD-1C patients inhibits non-insulin-stimulated glucose metabolism and growth but promotes myocyte proliferation.

Cell Biol Int 2019 Apr 8. Epub 2019 Apr 8.

Department of Physiology, School of Basic Medical Sciences, Guangxi Medical University, Nanning, Guangxi, China, 2 Department of Endocrinology, Guangxi Medical University First Affiliated Hospital, Nanning, Guangxi, China.

The caveolin-3 (CAV3) protein is known to be specifically expressed in various myocytes, and skeletal muscle consumes most of the blood glucose as an energy source to maintain normal cell metabolism and function. The P104L mutation in the coding sequence of the human CAV3 gene leads to the autosomal dominant disease limb-girdle muscular dystrophy type 1C (LGMD-1C). We previously reported that C2C12 cells transiently transfected with the P104L CAV3 mutant exhibited decreased glucose uptake and glycogen synthesis after insulin stimulation. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cbin.11144DOI Listing
April 2019
3 Reads

Precise therapeutic gene correction by a simple nuclease-induced double-stranded break.

Nature 2019 Apr 3. Epub 2019 Apr 3.

Department of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School, Worcester, MA, USA.

Current programmable nuclease-based methods (for example, CRISPR-Cas9) for the precise correction of a disease-causing genetic mutation harness the homology-directed repair pathway. However, this repair process requires the co-delivery of an exogenous DNA donor to recode the sequence and can be inefficient in many cell types. Here we show that disease-causing frameshift mutations that result from microduplications can be efficiently reverted to the wild-type sequence simply by generating a DNA double-stranded break near the centre of the duplication. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41586-019-1076-8DOI Listing
April 2019
2 Reads

Autosomal recessive limb-girdle and Miyoshi muscular dystrophies in the Netherlands: the clinical and molecular spectrum of 244 patients.

Clin Genet 2019 Mar 28. Epub 2019 Mar 28.

Department of Clinical Genetics, Leiden University Medical Centre, Leiden, The Netherlands.

In this retrospective study we conducted a clinico-genetic analysis of patients with autosomal recessive limb girdle muscular dystrophy (LGMD) and Miyoshi muscular dystrophy (MMD). Patients were identified at the tertiary referral centre for DNA diagnosis in the Netherlands and included if they carried two mutations in either CAPN3, DYSF, SGCG, SGCA, SGCB, SGCD, TRIM32, FKRP or ANO5 gene. DNA was screened by direct sequencing and multiplex ligand-dependent probe amplification (MLPA) analysis. Read More

View Article

Download full-text PDF

Source
https://onlinelibrary.wiley.com/doi/abs/10.1111/cge.13544
Publisher Site
http://dx.doi.org/10.1111/cge.13544DOI Listing
March 2019
5 Reads

Analysis of the Zn-Binding Domains of TRIM32, the E3 Ubiquitin Ligase Mutated in Limb Girdle Muscular Dystrophy 2H.

Cells 2019 Mar 16;8(3). Epub 2019 Mar 16.

Department of Life Sciences, University of Trieste, 34127 Trieste, Italy.

Members of the tripartite motif family of E3 ubiquitin ligases are characterized by the presence of a conserved N-terminal module composed of a RING domain followed by one or two B-box domains, a coiled-coil and a variable C-terminal region. The RING and B-box are both Zn-binding domains but, while the RING is found in a large number of proteins, the B-box is exclusive to the tripartite motif (TRIM) family members in metazoans. Whereas the RING has been extensively characterized and shown to possess intrinsic E3 ligase catalytic activity, much less is known about the role of the B-box domains. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cells8030254DOI Listing
March 2019
1 Read

Value of structured reporting in neuromuscular disorders.

Radiol Med 2019 Mar 9. Epub 2019 Mar 9.

Neuroradiology Department, IRCCS C. Mondino Foundation, Pavia, Italy.

Objective: To assess whether structured reports (SRs) of MRI in patients with inherited neuromuscular disorders (IND) provide more clinically relevant information than non-structured reports (NSRs) and whether neuroradiologists' expertise affects completeness of reports.

Material And Methods: Lower limbs' MRI reports of patients with IND produced by neuroradiologists with different level of expertise (> 15 years vs. < 15 years of experience in reading IND-MRI) before and after implementation of a SR template were included. Read More

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11547-019-01012-0
Publisher Site
http://dx.doi.org/10.1007/s11547-019-01012-0DOI Listing
March 2019
6 Reads
1.368 Impact Factor

Growth Factor Screening in Dystrophic Muscles Reveals PDGFB/PDGFRB-Mediated Migration of Interstitial Stem Cells.

Int J Mol Sci 2019 Mar 5;20(5). Epub 2019 Mar 5.

Laboratory of Translational Cardiomyology, Department of Development and Regeneration, Stem Cell Research Institute, KU Leuven, 3000 Leuven, Belgium.

Progressive muscle degeneration followed by dilated cardiomyopathy is a hallmark of muscular dystrophy. Stem cell therapy is suggested to replace diseased myofibers by healthy myofibers, although so far, we are faced by low efficiencies of migration and engraftment of stem cells. Chemokines are signalling proteins guiding cell migration and have been shown to tightly regulate muscle tissue repair. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/ijms20051118DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429448PMC
March 2019
2 Reads

Gene Delivery for Limb-Girdle Muscular Dystrophy Type 2D (LGMD2D).

Hum Gene Ther 2019 Mar 6. Epub 2019 Mar 6.

Columbus, Ohio, United States ;

(Word Count 280) In a previous LGMD2D clinical trial, robust alpha-sarcoglycan (αSG) gene expression was confirmed following intramuscular gene (SGCA) transfer. This paved the way for first in-human isolated limb infusion (ILI) gene transfer trial to the lower limbs. Delivery of scAAVrh74. Read More

View Article

Download full-text PDF

Source
https://www.liebertpub.com/doi/10.1089/hum.2019.006
Publisher Site
http://dx.doi.org/10.1089/hum.2019.006DOI Listing
March 2019
8 Reads

Childhood onset limb-girdle muscular dystrophies in the Aegean part of Turkey.

Acta Myol 2018 09 1;37(3):210-220. Epub 2018 Sep 1.

University Hospital Cologne, Department of Pediatrics, Cologne, Germany.

The aim of this study is to analyze the epidemiology of the clinical and genetic features of childhood-onset limb-girdle muscular dystrophies (LGMD) in the Aegean part of Turkey. In total fifty-six pediatric cases with LGMD followed in four different pediatric neurology departments in the Aegean region of Turkey were evaluated. Among them, LGMD2C was the most common followed by LGMD2A, LGMD2D, and LGMD2F with equal frequencies. Read More

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6390111PMC
September 2018
1 Read

Limb-girdle Muscular Dystrophy with New Mutation in Sarcoglycan Beta Gene: A Case Report.

Iran J Public Health 2018 Dec;47(12):1953-1957

Dept. of Medical Genetics, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

Limb-girdle muscular dystrophies (LGMDs) are a large group of genetic diseases in which there is muscle weakness and they are heterogonous diseases. The following study conducted in September 2017 in Mashhad, northwest of southern Khorasan Province, Iran reports a four years girl of autosomal recessive LGMD with proximal weakness and myopathy patterns. We detected four new alternations in this patient not reported for our population. Read More

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6379601PMC
December 2018
1 Read

Clinical and genetic spectrum of sarcoglycanopathies in a large cohort of Chinese patients.

Orphanet J Rare Dis 2019 02 14;14(1):43. Epub 2019 Feb 14.

Department of Neurology, Peking University First Hospital, 8 Xishiku St, Xicheng District, Beijing, 100034, China.

Background: Sarcoglycanopathies comprise four subtypes of autosomal recessive limb-girdle muscular dystrophy (LGMD2C, LGMD2D, LGMD2E, and LGMD2F) that are caused, respectively, by mutations in the SGCG, SGCA, SGCB, and SGCD genes. Knowledge about the clinical and genetic features of sarcoglycanopathies in Chinese patients is limited. The aims of this study were to investigate in detail the clinical manifestations, sarcoglycan expression, and gene mutations in Chinese patients with sarcoglycanopathies and to identify possible correlations between them. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13023-019-1021-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6376703PMC
February 2019
3 Reads

Frequency of reported pain in adult males with muscular dystrophy.

PLoS One 2019 14;14(2):e0212437. Epub 2019 Feb 14.

Musculoskeletal Science & Sports Medicine Research Centre, School of Healthcare Science, Faculty of Science and Engineering, Manchester Metropolitan University, Manchester, United Kingdom.

Introduction: The purpose of this study was to present and compare pain between adult males with Duchenne (DMD), Becker's (BMD), Limb-Girdle (LGMD) Facioscapulohumeral (FSHD) forms of Muscular Dystrophy (MD), and healthy controls (CTRL), using three different methods of assessment.

Methods: Pain was assessed using 1) a whole body visual analogue scale (VAS) of pain, 2) a generalised body map and 3) a localised body map.

Results: All types of MD reported more VAS pain than CTRL, with 97% of all MD participants reporting pain; however, no differences were reported between types of MD. Read More

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0212437PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6375632PMC
February 2019
1 Read

Homozygous Nonsense Mutation (p.Arg97) Causing Limb-Girdle Muscular Dystrophy Type 2F (LGMD2F) in a Consanguineous Family, a Case Report.

Front Genet 2018 23;9:727. Epub 2019 Jan 23.

Department of Biochemistry, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad, Pakistan.

Limb-girdle muscular dystrophy (LGMD) is an increasingly heterogeneous category of inherited muscle diseases, mainly affecting the muscles of shoulder areas and the hip, segregating in both autosomal recessive and dominant manner. To-date, thirty-one loci have been identified for LGMD including seven autosomal dominant (LGMD type 1) and twenty four autosomal recessive (LGMD type 2) inherited loci. The present report describes a consanguineous family segregating LGMD2F in an autosomal recessive pattern. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fgene.2018.00727DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354032PMC
January 2019
3 Reads

[Variant analysis for a pedigree affected with limb-girdle muscular dystrophy type 2D].

Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2019 Feb;36(2):136-139

School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China.

Objective: To analyze variant of SGCA gene in a Chinese pedigree affected with limb-girdle muscular dystrophy type 2D with whole exome sequencing (WGS).

Methods: Multiplex ligation-dependent probe amplification (MLPA) was employed to detect large fragment deletion or duplication of the DMD gene. FastTarget next generation sequencing was used to detect variants of the DMD gene, and the result was verified by Sanger sequencing. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3760/cma.j.issn.1003-9406.2019.02.010DOI Listing
February 2019
3 Reads

Limb-girdle muscular dystrophy due to GMPPB mutations: A case report and comprehensive literature review.

Bosn J Basic Med Sci 2019 Jan 16. Epub 2019 Jan 16.

Department of Neurology, Hainan Branch of Chinese PLA General Hospital, Sanya, Hainan Province, China.

Mutations in the guanosine diphosphate mannose (GDP-mannose) pyrophosphorylase B (GMPPB) gene are rare. To date, 72 cases with GMPPB gene mutations have been reported. Herein, we reported a case of a 29-year-old Chinese male presenting with limb-girdle muscular dystrophy (LGMD) who was found to have two heterozygous GMPPB mutations. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.17305/bjbms.2019.3992DOI Listing
January 2019

Limb girdle muscular dystrophy D3 HNRNPDL related in a Chinese family with distal muscle weakness caused by a mutation in the prion-like domain.

J Neurol 2019 Feb 2;266(2):498-506. Epub 2019 Jan 2.

Department of Neurology, Mayo Clinic, Rochester, MN, 55905, USA.

Limb-girdle muscular dystrophies (LGMD) are a group of clinically and genetically heterogeneous diseases characterized by weakness and wasting of the pelvic and shoulder girdle muscles. Twenty-four recessive LGMD (types R1-R24) and five dominant LGMD (types D1-D5) have been identified with characterization of mutations in various genes. To date, LGMD D3 (previously known as LGMD1G) has been characterized in only two families with Brazilian or Uruguayan origin. Read More

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00415-018-9165-4
Publisher Site
http://dx.doi.org/10.1007/s00415-018-9165-4DOI Listing
February 2019
3 Reads

Anti-HMGCR myopathy may resemble limb-girdle muscular dystrophy.

Neurol Neuroimmunol Neuroinflamm 2019 Jan 12;6(1):e523. Epub 2018 Dec 12.

National Institutes of Health (P.M., A.R.F., S.D., C.G.B.), NINDS, NNDCS, Bethesda, MD; Department of Internal Medicine and Clinical Immunology (O.L.-C., Y.A., O.B.), Sorbonne Universités, University Pierre et Marie et Curie, APHP, Hôpital Pitié-Salpêtrière, Paris, France; National Institutes of Health (K.P., A.L.M.), NIAMS; National Institutes of Health (C.W., C.T.), NHGRI, UDP, Bethesda, MD; Department of Neurology (R.T.S.), University of Miami, Miami, FL; Department of Neurology (A.H.), Virginia Commonwealth University, Richmond, VA; Division of Pediatric Neurology (P.F.), Department of Pediatrics, University of Alabama, Birmingham; Department of Neurological Sciences (M.M.), Rush University Medical Center, Chicago, IL; Department of Neurology (D.D., A.L.M.), Department of Medicine (A.L.M.), Johns Hopkins University, Baltimore, MD; AP-HP (A.B., B.E., T.S.), G-H Pitié-Salpêtrière, Institut de Myologie, Paris; and Neurology Department (P.L.), Raymond Poincaré Hospital, Garches, APHP and INSERM U1179, END-ICAP, Versailles Saint-Quentin-en-Yvelines University, Montigny-le-Bretonneux, France.

Objective: To determine the prevalence and clinical features of anti-HMGCR myopathy among patients with presumed limb-girdle muscular dystrophy (LGMD) in whom genetic testing has failed to elucidate causative mutations.

Methods: Patients with presumed LGMD and unrevealing genetic testing were selected based on a few clinico-pathologic features and tested for anti-HMGCR autoantibodies (n = 11). These clinico-pathologic features are peak creatine kinase (CK) greater than 1,000 IU/L and at least 3 of the following features: (1) limb-girdle pattern of weakness, (2) selective involvement of posterior thigh on clinical examination or muscle imaging, (3) dystrophic changes on muscle biopsy, and (4) no family history of muscular dystrophy. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/NXI.0000000000000523DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6292490PMC
January 2019
22 Reads

[Coincidence of hereditary motor and sensory neuropathy type 1A and limb girdle muscular dystrophy type 2A].

Zh Nevrol Psikhiatr Im S S Korsakova 2018;118(11):72-76

FSBI Research Centre for Medical Genetics, Moskvorechie 1, 115522 Moscow, Russia.

A rare case of two neuromuscular disorders in a 29-year-old female is presented: autosomal dominant hereditary motor and sensory neuropathy type 1A (HMSN1A) due to PMP22 duplication and autosomal recessive limb girdle muscular dystrophy type 2A (LGMD2A) produced by CAPN3 common mutation c.550delA and novel c.575C>G (p. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.17116/jnevro201811811172DOI Listing
January 2018
2 Reads

[Clinical and genetic features of limb-girdle muscular dystrophy type 1B: a case report].

Zhongguo Dang Dai Er Ke Za Zhi 2018 Dec;20(12):1015-1019

Department of Pediatrics, First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China.

This article reports a case of limb-girdle muscular dystrophy type 1B (LGMD1B) caused by a novel splicing heterozygous mutation in the LMNA gene. The proband presented with progressive aggravation of weakness in walking. There was no atrophy of the scapular muscles and the lower-extremity proximal muscles, with normal muscle tension of the extremities, grade 4 muscle strength in the upper and lower extremities, and positive Gower sign. Read More

View Article

Download full-text PDF

Source
December 2018
2 Reads

Genetic landscape and novel disease mechanisms from a large LGMD cohort of 4656 patients.

Ann Clin Transl Neurol 2018 Dec 1;5(12):1574-1587. Epub 2018 Dec 1.

Emory University Department of Human Genetics Atlanta Georgia 30322.

Objective: Limb-girdle muscular dystrophies (LGMDs), one of the most heterogeneous neuromuscular disorders (NMDs), involves predominantly proximal-muscle weakness with >30 genes associated with different subtypes. The clinical-genetic overlap among subtypes and with other NMDs complicate disease-subtype identification lengthening diagnostic process, increases overall costs hindering treatment/clinical-trial recruitment. Currently seven LGMD clinical trials are active but still no gene-therapy-related treatment is available. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/acn3.649DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6292381PMC
December 2018
4 Reads

Human iPSC Models to Study Orphan Diseases: Muscular Dystrophies.

Curr Stem Cell Rep 2018 4;4(4):299-309. Epub 2018 Oct 4.

3Houston Methodist Neurological Institute and Research Institute, 6670 Bertner Ave R11-117, Houston, TX USA.

Purpose Of Review: Muscular dystrophies (MDs) are a spectrum of muscle disorders, which are caused by a number of gene mutations. The studies of MDs are limited due to lack of appropriate models, except for Duchenne muscular dystrophy (DMD), myotonic dystrophy type 1 (DM1), facioscapulohumeral muscular dystrophy (FSHD), and certain type of limb-girdle muscular dystrophy (LGMD). Human induced pluripotent stem cell (iPSC) technologies are emerging to offer a useful model for mechanistic studies, drug discovery, and cell-based therapy to supplement in vivo animal models. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40778-018-0145-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6244555PMC
October 2018
3 Reads

Prevalence, pathological mechanisms, and genetic basis of limb-girdle muscular dystrophies: A review.

J Cell Physiol 2019 Jun 7;234(6):7874-7884. Epub 2018 Dec 7.

Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Science, Mashhad, Iran.

Limb-girdle muscular dystrophies (LGMDs) are a highly heterogeneous group of neuromuscular disorders that are associated with weakness and wasting of muscles in legs and arms. Signs and symptoms may begin at any age and usually worsen by time. LGMDs are autosomal disorders with different types and their prevalence is not the same in different areas. Read More

View Article

Download full-text PDF

Source
https://onlinelibrary.wiley.com/doi/abs/10.1002/jcp.27907
Publisher Site
http://dx.doi.org/10.1002/jcp.27907DOI Listing
June 2019
23 Reads
3.839 Impact Factor

Recessive PYROXD1 mutations cause adult-onset limb-girdle-type muscular dystrophy.

J Neurol 2019 Feb 4;266(2):353-360. Epub 2018 Dec 4.

Research Programs Unit, Molecular Neurology, University of Helsinki, Helsinki, Finland.

Objective: To describe adult-onset limb-girdle-type muscular dystrophy caused by biallelic variants in the PYROXD1 gene, which has been recently linked to early-onset congenital myofibrillar myopathy.

Methods: Whole exome sequencing was performed for adult-onset neuromuscular disease patients with no molecular diagnosis. Patients with PYROXD1 variants underwent clinical characterization, lower limb muscle MRI, muscle biopsy and spirometry. Read More

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00415-018-9137-8
Publisher Site
http://dx.doi.org/10.1007/s00415-018-9137-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373352PMC
February 2019
20 Reads
3.380 Impact Factor

Divergent Features of Mitochondrial Deficiencies in LGMD2A Associated With Novel Calpain-3 Mutations.

J Neuropathol Exp Neurol 2019 Jan;78(1):88-98

Neuromuscular Diagnostic Laboratory, Department of Pathology and Laboratory Medicine, American University of Beirut Medical Center, Beirut, Lebanon.

Limb girdle muscular dystrophy type 2A (LGMD2A) is an autosomal recessive disorder characterized by progressive muscle weakness and wasting. LGMD2A is caused by mutations in the calpain-3 gene (CAPN3) that encodes a Ca2+-dependent cysteine protease predominantly expressed in the skeletal muscle. Underlying pathological mechanisms have not yet been fully elucidated. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnen/nly113DOI Listing
January 2019
5 Reads
3.797 Impact Factor

High-throughput data-driven analysis of myofiber composition reveals muscle-specific disease and age-associated patterns.

FASEB J 2019 Mar 28;33(3):4046-4053. Epub 2018 Nov 28.

Molecular Epidemiology, Leiden University Medical Centre, Leiden, The Netherlands.

Contractile properties of myofibers are dictated by the abundance of myosin heavy chain (MyHC) isoforms. MyHC composition designates muscle function, and its alterations could unravel differential muscle involvement in muscular dystrophies and aging. Current analyses are limited to visual assessments in which myofibers expressing multiple MyHC isoforms are prone to misclassification. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1096/fj.201801714RDOI Listing
March 2019
2 Reads

Molecular genetics of the POMT1-related muscular dystrophy-dystroglycanopathies.

Mutat Res 2018 Oct - Dec;778:45-50. Epub 2018 Sep 12.

Center for Experimental Medicine, the Third Xiangya Hospital, Central South University, Changsha, PR China. Electronic address:

Protein O-mannosyltransferase 1 (POMT1) is a critical enzyme participating in the first step of protein O-mannosylation. Mutations in the coding gene, POMT1, have been described to be related to a series of autosomal recessive disorders associated with defective alpha-dystroglycan glycosylation, later termed muscular dystrophy-dystroglycanopathies (MDDGs). MDDGs are characterized by a broad phenotypic spectrum of congenital muscular dystrophy or later-onset limb-girdle muscular dystrophy, accompanied by variable degrees of intellectual disability, brain defects, and ocular abnormalities. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mrrev.2018.09.002DOI Listing
April 2019
12 Reads

Whole exome sequencing identified a novel DAG1 mutation in a patient with rare, mild and late age of onset muscular dystrophy-dystroglycanopathy.

J Cell Mol Med 2019 Feb 18;23(2):811-818. Epub 2018 Nov 18.

Department of Cell Biology and Medical Genetics, School of Medicine, Zhejiang University, Hangzhou, China.

Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 9 (MDDGC9) is the rarest type of autosomal recessive muscular dystrophies. MDDGC9 is manifested with an early onset in childhood. Patients with MDDGC9 usually identified with defective glycosylation of DAG1, hence it is known as "dystroglycanopathies". Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jcmm.13979DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349151PMC
February 2019
18 Reads

Cardiac Phenotypes in Hereditary Muscle Disorders: JACC State-of-the-Art Review.

J Am Coll Cardiol 2018 Nov;72(20):2485-2506

Centre for Inherited Cardiovascular Diseases, IRCCS Foundation, University Hospital Policlinico San Matteo, Pavia, Italy.

Hereditary muscular diseases commonly involve the heart. Cardiac manifestations encompass a spectrum of phenotypes, including both cardiomyopathies and rhythm disorders. Common biomarkers suggesting cardiomuscular diseases include increased circulating creatine kinase and/or lactic acid levels or disease-specific metabolic indicators. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S07351097183858
Publisher Site
http://dx.doi.org/10.1016/j.jacc.2018.08.2182DOI Listing
November 2018
22 Reads

Toxic Myopathy due to Antidopaminergic Medication Without Neuroleptic Malignant Syndrome.

J Clin Neuromuscul Dis 2018 Dec;20(2):94-98

Departments of Pediatrics and.

Severe recurrent proximal muscle weakness without neuroleptic malignant syndrome secondary to antidopaminergic medication has rarely been reported. We report a 29-year-old man with history of obsessive compulsive disorder and Tourette syndrome who presented with 2 months of worsening dyspnea 3 weeks after starting ziprasidone 40 mg daily that required mechanical ventilation. A year before, after an increased risperidone dose from 0. Read More

View Article

Download full-text PDF

Source
http://Insights.ovid.com/crossref?an=00131402-201812000-0000
Publisher Site
http://dx.doi.org/10.1097/CND.0000000000000233DOI Listing
December 2018
32 Reads

Identification of Novel Antisense-Mediated Exon Skipping Targets in DYSF for Therapeutic Treatment of Dysferlinopathy.

Mol Ther Nucleic Acids 2018 Dec 11;13:596-604. Epub 2018 Oct 11.

Department of Medical Genetics, University of Alberta, Edmonton, AB, Canada; The Friends of Garrett Cumming Research & Muscular Dystrophy Canada HM Toupin Neurological Science Research Chair, Edmonton, AB T6G 2H7, Canada. Electronic address:

Dysferlinopathy is a progressive myopathy caused by mutations in the dysferlin (DYSF) gene. Dysferlin protein plays a major role in plasma-membrane resealing. Some patients with DYSF deletion mutations exhibit mild symptoms, suggesting some regions of DYSF can be removed without significantly impacting protein function. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.omtn.2018.10.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6234522PMC
December 2018
2 Reads

Severe limb-girdle muscular dystrophy 2A in two young siblings from Guinea-Bissau associated with a novel null homozygous mutation in CAPN3 gene.

Neuromuscul Disord 2018 Dec 9;28(12):1003-1005. Epub 2018 Oct 9.

Department of Neurosciences and Mental Health, Hospital de Santa Maria, Centro Hospitalar Lisboa Norte, Avenida Professor Egas Moniz, 1649-035 Lisbon, Portugal; Faculty of Medicine, Institute of Physiology Unit, Instituto de Medicina Molecular, Universidade de Lisboa, Avenida Professor Egas Moniz, 1649-035 Lisbon, Portugal.

Limb-girdle muscular dystrophy 2A (LGMD2A) or calpainopathy is the most common type of LGMD worldwide, representing about 30-40% of all described cases. Nevertheless, its prevalence in sub-Saharan African countries is unknown. We report two young siblings from Guinea-Bissau with recessive calpainopathy due to novel null homozygous c. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.nmd.2018.09.009DOI Listing
December 2018
5 Reads

Cervical Hyperextension Deformity After Sagittal Balance Correction in Patient with Congenital Limb-Girdle Myopathy: Surgical Technique and Review of Literature.

World Neurosurg 2019 Mar 9;123:265-271. Epub 2018 Nov 9.

Department of Neurosurgery, Hotel Dieu de France Hospital, Beirut, Lebanon. Electronic address:

Background: There is no gold standard surgical treatment for cervical hyperextension deformity, especially in case of muscular dystrophy. Special considerations and caution should be taken as they carry a high risk of early mortality and spinal cord injury. Only a few case reports are available in the literature. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.wneu.2018.10.211DOI Listing
March 2019
5 Reads

Modeling Skeletal Muscle Laminopathies Using Human Induced Pluripotent Stem Cells Carrying Pathogenic Mutations.

Front Physiol 2018 15;9:1332. Epub 2018 Oct 15.

Department of Cell and Developmental Biology, University College London, London, United Kingdom.

Laminopathies are a clinically heterogeneous group of disorders caused by mutations in . The main proteins encoded by are Lamin A and C, which together with Lamin B1 and B2, form the nuclear lamina: a mesh-like structure located underneath the inner nuclear membrane. Laminopathies show striking tissue specificity, with subtypes affecting striated muscle, peripheral nerve, and adipose tissue, while others cause multisystem disease with accelerated aging. Read More

View Article

Download full-text PDF

Source
https://www.frontiersin.org/article/10.3389/fphys.2018.01332
Publisher Site
http://dx.doi.org/10.3389/fphys.2018.01332DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6201196PMC
October 2018
12 Reads

Three novel recessive DYSF mutations identified in three patients with muscular dystrophy, limb-girdle, type 2B.

J Neurol Sci 2018 12 16;395:169-171. Epub 2018 Oct 16.

Department of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan; Department of Clinical Genome Analysis, Medical Genome Center, National Center of Neurology and Psychiatry, Tokyo, Japan. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S0022510X183042
Publisher Site
http://dx.doi.org/10.1016/j.jns.2018.10.015DOI Listing
December 2018
17 Reads
2.474 Impact Factor

New DEStiny Revealed.

Circulation 2018 Sep;138(12):1267-1271

Bluhm Cardiovascular Institute (G.A., B.P.K., S.J.S., E.M.M.), Northwestern University Feinberg School of Medicine, Chicago IL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.118.035577DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6260957PMC
September 2018
7 Reads

Impact of PYROXD1 deficiency on cellular respiration and correlations with genetic analyses of limb-girdle muscular dystrophy in Saudi Arabia and Sudan.

Physiol Genomics 2018 Nov 31;50(11):929-939. Epub 2018 Aug 31.

Division of Pediatric Neurology, Department of Pediatrics, University of Florida College of Medicine , Gainesville, Florida.

Next-generation sequencing is commonly used to screen for pathogenic mutations in families with Mendelian disorders, but due to the pace of discoveries, gaps have widened for some diseases between genetic and pathophysiological knowledge. We recruited and analyzed 16 families with limb-girdle muscular dystrophy (LGMD) of Arab descent from Saudi Arabia and Sudan who did not have confirmed genetic diagnoses. The analysis included both traditional and next-generation sequencing approaches. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1152/physiolgenomics.00036.2018DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6293114PMC
November 2018
13 Reads
1 Citation
2.374 Impact Factor

Small mutation screening in the DMD gene by whole exome sequencing of an argentine Duchenne/Becker muscular dystrophies cohort.

Neuromuscul Disord 2018 Dec 6;28(12):986-995. Epub 2018 Sep 6.

Departamento de Microbiología, Inmunología, Biotecnología y Genética, Cátedra de Genética, Laboratorio de Distrofinopatías, Universidad de Buenos Aires, Laboratorio de Distrofinopatías Junín 956, C.A.B.A., C.P. 1113, Buenos Aires, Argentina; Instituto de Inmunología, Genética y Metabolismo (INIGEM), CONICET - Universidad de Buenos Aires, Buenos Aires, Argentina.

Dystrophinopathies are neuromuscular X-linked recessive diseases caused by mutations in the DMD gene. This study aimed to identify DMD gene small mutations by Whole Exome Sequencing (WES), in order to confirm clinical diagnosis, identify candidates for Ataluren treatment and perform carrier status testing. Furthermore, was our goal to characterize the DMD sequence variants and identify ancestral haplotypes. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S09608966183012
Publisher Site
http://dx.doi.org/10.1016/j.nmd.2018.08.012DOI Listing
December 2018
6 Reads

Relationships between muscle size, strength, and physical activity in adults with muscular dystrophy.

J Cachexia Sarcopenia Muscle 2018 Dec 19;9(6):1042-1052. Epub 2018 Oct 19.

Research Centre for Musculoskeletal Science and Sports Medicine, School of Healthcare Science, Faculty of Science and Engineering, Manchester Metropolitan University, Manchester, UK.

Background: Muscular dystrophy (MD) is characterized by progressive muscle wasting and weakness, yet few comparisons to non-MD controls (CTRL) of muscle strength and size in this adult population exist. Physical activity (PA) is promoted to maintain health and muscle strength within MD; however, PA reporting in adults with MD is limited to recall data, and its impact on muscle strength is seldom explored.

Methods: This study included 76 participants: 16 non-MD (CTRL, mean age 35. Read More

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/jcsm.12347
Publisher Site
http://dx.doi.org/10.1002/jcsm.12347DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6240748PMC
December 2018
30 Reads

Limb Girdle Muscular Dystrophy due to Digenic Inheritance of and Mutations.

Case Rep Neurol 2018 Sep-Dec;10(3):272-278. Epub 2018 Sep 18.

Neuroscience Institute, Saint Francis Medical Center, Trenton, New Jersey, USA.

We report the clinical and genetic analysis of a 63-year-old man with progressive weakness developing over more than 20 years. Prior to his initial visit, he underwent multiple neurological and rheumatological evaluations and was treated for possible inflammatory myopathy. He did not respond to any treatment that was prescribed and was referred to our center for another opinion. Read More

View Article

Download full-text PDF

Source
https://www.karger.com/Article/FullText/492664
Publisher Site
http://dx.doi.org/10.1159/000492664DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6180278PMC
September 2018
16 Reads

Intramuscular interstitial amyloid deposition does not impact anoctaminopathy-5 phenotype.

Muscle Nerve 2019 Jan 17;59(1):133-137. Epub 2018 Oct 17.

Department of Neurology, Mayo Clinic, 200 First Street SW, Rochester, Minnesota, 55905, USA.

Introduction: Recessive mutations in the anoctamin-5-encoding gene (ANO5) cause muscular dystrophy of various phenotypes. Intramuscular interstitial amyloid deposits were detected in a few patients with anoctaminopathy-5, some with cardiac involvement. The frequency of amyloid deposition in anoctaminopathy-5 and its impact on phenotype are unknown. Read More

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/mus.26349
Publisher Site
http://dx.doi.org/10.1002/mus.26349DOI Listing
January 2019
15 Reads

Xanthine oxidase is hyper-active in Duchenne muscular dystrophy.

Free Radic Biol Med 2018 Dec 10;129:364-371. Epub 2018 Oct 10.

Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, USA.

Generation of superoxide by xanthine oxidase can be stimulated under ischemic and aberrant calcium homeostasis. Because patients and mice with Duchenne muscular dystrophy (DMD) suffer from ischemia and excessive calcium influx, we tested the hypothesis that xanthine oxidase activity is elevated and contributes to disease pathology. Xanthine oxidase activity was measured by urinary isoxanthopterin in DMD patients at rest and in response to exercise. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S08915849183131
Publisher Site
http://dx.doi.org/10.1016/j.freeradbiomed.2018.10.404DOI Listing
December 2018
24 Reads

Hippo signaling pathway is altered in Duchenne muscular dystrophy.

PLoS One 2018 10;13(10):e0205514. Epub 2018 Oct 10.

Unit of Neurology and Neuromuscular Diseases, Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.

Hippo signaling pathway is considered a key regulator of tissue homeostasis, cell proliferation, apoptosis and it is involved in cancer development. In skeletal muscle, YAP, a downstream target of the Hippo pathway, is an important player in myoblast proliferation, atrophy/hypertrophy regulation, and in mechano-trasduction, transferring mechanical signals into transcriptional responses. We studied components of Hippo pathway in muscle specimens from patients with Duchenne muscular dystrophy (DMD), Becker muscular dystrophy, limb-girdle muscular dystrophy type 2A and type 2B and healthy subjects. Read More

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0205514PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6179272PMC
March 2019
7 Reads

Exon Skipping in a Dysf-Missense Mutant Mouse Model.

Mol Ther Nucleic Acids 2018 Dec 22;13:198-207. Epub 2018 Aug 22.

Muscle Research Unit, Experimental and Clinical Research Center (ECRC), a cooperation between the Charité, Universitätsmedizin Berlin and the Max- Delbrück- Center for Molecular Medicine, 13125 Berlin, Germany; Max Delbrück Center for Molecular Medicine in the Helmholtz Association, 13125 Berlin, Germany; Berlin Institute of Health, 10178 Berlin, Germany.

Limb girdle muscular dystrophy 2B (LGMD2B) is without treatment and caused by mutations in the dysferlin gene (DYSF). One-third is missense mutations leading to dysferlin aggregation and amyloid formation, in addition to defects in sarcolemmal repair and progressive muscle wasting. Dysferlin-null mouse models do not allow study of the consequences of missense mutations. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S21622531183022
Publisher Site
http://dx.doi.org/10.1016/j.omtn.2018.08.013DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6172476PMC
December 2018
10 Reads

Structural characterization of the D290V mutation site in hnRNPA2 low-complexity-domain polymers.

Proc Natl Acad Sci U S A 2018 10 2;115(42):E9782-E9791. Epub 2018 Oct 2.

Department of Biochemistry, University of Texas Southwestern Medical Center, Dallas, TX 75390

Human genetic studies have given evidence of familial, disease-causing mutations in the analogous amino acid residue shared by three related RNA binding proteins causative of three neurological diseases. Alteration of aspartic acid residue 290 of hnRNPA2 to valine is believed to predispose patients to multisystem proteinopathy. Mutation of aspartic acid 262 of hnRNPA1 to either valine or asparagine has been linked to either amyotrophic lateral sclerosis or multisystem proteinopathy. Read More

View Article

Download full-text PDF

Source
http://www.pnas.org/lookup/doi/10.1073/pnas.1806174115
Publisher Site
http://dx.doi.org/10.1073/pnas.1806174115DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6196502PMC
October 2018
5 Reads

Anoctamin 5/TMEM16E facilitates muscle precursor cell fusion.

J Gen Physiol 2018 Nov 26;150(11):1498-1509. Epub 2018 Sep 26.

Department of Cell Biology, Emory University School of Medicine, Atlanta, GA

Limb-girdle muscular dystrophy type 2L (LGMD2L) is a myopathy arising from mutations in ; however, information about the contribution of ANO5 to muscle physiology is lacking. To explain the role of ANO5 in LGMD2L, we previously hypothesized that ANO5-mediated phospholipid scrambling facilitates cell-cell fusion of mononucleated muscle progenitor cells (MPCs), which is required for muscle repair. Here, we show that heterologous overexpression of ANO5 confers Ca-dependent phospholipid scrambling to HEK-293 cells and that scrambling is associated with the simultaneous development of a nonselective ionic current. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1085/jgp.201812097DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6219693PMC
November 2018
25 Reads

Broad phenotypic spectrum and genotype-phenotype correlations in GMPPB-related dystroglycanopathies: an Italian cross-sectional study.

Orphanet J Rare Dis 2018 09 26;13(1):170. Epub 2018 Sep 26.

Department of Developmental Neuroscience and Molecular Medicine Neuromuscular Unit and Child Neurology, IRCCS Fondazione Stella Maris, Via dei Giacinti 2, 56018, Pisa, Italy.

Background: Dystroglycanopathy (α-DG) is a relatively common, clinically and genetically heterogeneous category of congenital forms of muscular dystrophy (CMD) and limb-girdle muscular dystrophy (LGMD) associated with hypoglycosylated α-dystroglycan. To date, mutations in at least 19 genes have been associated with α-DG. One of them, GMPPB, encoding the guanosine-diphosphate-mannose (GDP-mannose) pyrophosphorylase B protein, has recently been associated with a wide clinical spectrum ranging from severe Walker-Warburg syndrome to pseudo-metabolic myopathy and even congenital myasthenic syndromes. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13023-018-0863-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6158856PMC
September 2018
15 Reads
3.358 Impact Factor

Insertion sequence 1 from calpain-3 is functional in calpain-2 as an internal propeptide.

J Biol Chem 2018 11 25;293(46):17716-17730. Epub 2018 Sep 25.

From the Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Ontario K7L 3N6, Canada

Calpains are intracellular, calcium-activated cysteine proteases. Calpain-3 is abundant in skeletal muscle, where its mutation-induced loss of function causes limb-girdle muscular dystrophy type 2A. Unlike the small subunit-containing calpain-1 and -2, the calpain-3 isoform homodimerizes through pairing of its C-terminal penta-EF-hand domain. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.RA118.004803DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6240860PMC
November 2018
8 Reads